Literature DB >> 9332316

Activation of neutrophil function via CD66: differential effects upon beta 2 integrin mediated adhesion.

M H Ruchaud-Sparagano1, S C Stocks, H Turley, I Dransfield.   

Abstract

To further define the role of CD66 glycoproteins in the regulation of neutrophil function, we analysed the effects of a CD66 monoclonal antibody, Kat4c, which recognizes an epitope present on AB domains of CD66a, CD66b and CD66c. Intact Kat4c and F(ab')2 fragments were found to augment fMLP-induced oxidation of 1,2,3-dihydrorhodamine (oxidant species production) and beta 2 integrin-mediated adhesion to fibrinogen but did not promote beta 2 integrin-mediated binding of albumin coated latex beads. Since the latter assay is a sensitive indicator of neutrophil CD11b/CD18 functional activation, these results imply CD66 may exert differential effects upon beta 2 integrin activity. Neutrophil oxidant species production and spreading on fibrinogen substrates were further potentiated by cross-linking of Kat4c F(ab')2, in keeping with the suggestion that ligation of CD66 regulates neutrophil function. However, although intact Kat4c promoted beta 2 integrin-dependent homotypic neutrophil adhesion, F(ab')2 fragments were without effect, implying a role for Fc receptors in this effect which has previously been attributed to CD66. Together these data define more clearly the role of CD66 in regulation of neutrophil function and further suggest that augmented beta 2 integrin-mediated adhesion following CD66 ligation occurs independently of affinity regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9332316     DOI: 10.1046/j.1365-2141.1997.2523070.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  The role of galectin-3 in phagocytosis of Candida albicans and Candida parapsilosis by human neutrophils.

Authors:  Jennifer R Linden; Dennis Kunkel; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Cell Microbiol       Date:  2013-01-20       Impact factor: 3.715

Review 2.  Interactions of integrins with their partner proteins in leukocyte membranes.

Authors:  Howard R Petty; Randall G Worth; Robert F Todd
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  GEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite-dependent mechanism.

Authors:  Emma L Taylor; Adriano G Rossi; Catherine A Shaw; Francesco P Dal Rio; Christopher Haslett; Ian L Megson
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

4.  CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children.

Authors:  Diana-Michaela Fitrolaki; Helen Dimitriou; Maria Kalmanti; George Briassoulis
Journal:  BMC Pediatr       Date:  2013-03-01       Impact factor: 2.125

5.  Homologue scanning mutagenesis reveals CD66 receptor residues required for neisserial Opa protein binding.

Authors:  M P Bos; D Hogan; R J Belland
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

6.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

7.  Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis.

Authors:  Paulo S Martins; Milena K C Brunialti; Leandro S W Martos; Flavia R Machado; Murillo S Assunçao; Sergio Blecher; Reinaldo Salomao
Journal:  Crit Care       Date:  2008-02-13       Impact factor: 9.097

8.  Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients.

Authors:  Rocio Aroca; Cristina Chamorro; Antonio Vega; Inmaculada Ventura; Elisa Gómez; Ramón Pérez-Cano; Miguel Blanca; Javier Monteseirín
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.